Rallybio Corp
For the period ended Dec 31, 2024. Filed Mar 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Mar 13, 2025
RLYB$15.66-0.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| (in thousands, except share and per share amounts) | DECEMBER 31,2024 | DECEMBER 31,2023 |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $13,903 | $24,494 |
| Marketable securities | 51,608 | 85,435 |
| Prepaid expenses and other assets | 2,330 | 4,860 |
| Total current assets | 67,841 | 114,789 |
| Property and equipment, net | 115 | 246 |
| Operating lease right-of-use assets | 152 | 346 |
| Investment in joint venture | — | 239 |
| Total assets | $68,108 | $115,620 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $278 | $976 |
| Accrued expenses | 4,962 | 8,068 |
| Operating lease liabilities | 154 | 219 |
| Deferred revenue | 848 | — |
| Total current liabilities | 6,242 | 9,263 |
| Operating lease liabilities, noncurrent | — | 173 |
| Deferred revenue, noncurrent | 212 | — |
| Total liabilities | 6,454 | 9,436 |
| Commitments and contingencies (Note 10) | ||
| Stockholders' equity | ||
| Common stock, $0.0001 par value per share; 200,000,000 shares authorized as of December 31, 2024 and 2023; and 41,510,163 and 37,829,565 shares issued and outstanding as of December 31, 2024 and 2023, respectively | 4 | 4 |
| Preferred stock, $0.0001 par value per share; 50,000,000 shares authorized as of December 31, 2024 and 2023; no shares issued or outstanding as of December 31, 2024 and 2023 | — | — |
| Additional paid-in capital | 354,602 | 341,410 |
| Accumulated other comprehensive gain | 68 | 15 |
| Accumulated deficit | (293,020) | (235,245) |
| Total stockholders' equity | 61,654 | 106,184 |
| Total liabilities and stockholders' equity | $68,108 | $115,620 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.